We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Prokarium Acquires Key Oral Vaccine Technology from Emergent BioSolutions

News   Jul 10, 2012

 
Prokarium Acquires Key Oral Vaccine Technology from Emergent BioSolutions
 
 
 

RELATED ARTICLES

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

Existing Drugs Could Be Key To Combatting Coronavirus Outbreak

News

Developing new drugs and vaccines to treat the coronavirus that causes COVID-19 can take years. Existing drugs may offer a possible quick response to the potential pandemic.

READ MORE

Breast and Kidney Cancer Drug Could Also Help Patients With Advanced Head and Neck Cancer

News

A targeted therapy drug already used for breast and kidney cancers may also extend progression-free survival of patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE